HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


UK’s OptiBiotix Launches Prebiotic Supplement Ingredient For European And African Markets

Executive Summary

Dietary supplement manufacturers interested in marketing prebiotics and synbiotics – combinations of pre- and post-biotics – in Europe and Africa now have the option of OptiBiotix's xylo-oligosaccharide prebiotic, OptiXOS, which the firm claims has superior stability and gastrointestinal tolerance.

You may also be interested in...

UK’s OptiBiotix Offers GoFigure Prebiotic Range To Slim Down Saudi Arabia’s ‘Alarming’ Obesity Rates

Thanks to a deal with local pharmacy chain Nahdi Medical, slimmers in the Kingdom of Saudi Arabia will soon be able to buy GoFigure shakes and bars, which contain OptiBiotix Health's trademarked SlimBiome prebiotic.

Over The Counter 28 Feb 2022: The Future Of EU Probiotics Regulation, With David Pineda Ereño

In this episode, HBW Insight talks probiotics with David Pineda Ereño, founder of DPE International Consulting and consultant to the International Probiotics Association. Since 2006, no health claims for probiotics have been allowed by harmonized European Union regulations. Even the term "probiotic" is considered an unauthorized health claim by the European Commission. However, as Pineda Ereño explains, many EU member states, including Italy and Spain, are starting to go their own way, adopting a more liberal approach to this booming wellness market. We discuss what the future of EU probiotics regulation may hold, as well as some recent exciting scientific developments, pointing to the health benefits of these extremely popular products.

UK Probiotics Distribution Deal Latest Milestone In OptiBiotix Growth Journey

UK probiotics specialist Optibiotix' CEO Stephen O'Hara speaks exclusively to HBW Insight about the firm's growth ambitions, which have not been held back by the coronavirus pandemic. 

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts